Mental health policy and practice across Europe: an overview

98 Mental health policy and practice
Rizzo, J., Abbott, T.A. and Pashko, S. (1996) Labour productivity effects of prescribed
medicines for chronically ill workers, Health Economics, 5(3): 249–65.
Romeo, R., Byford, S. and Knapp, M. (2005) Economic evaluations of child and adolescent
mental health interventions: a systematic review, Journal of Child Psychology and
Psychiatry, 46(9): 919–30.
Romeo, R., Knapp, M. and Scott, S. (2006) Economic cost of severe antisocial behaviour in
children – and who pays it? British Journal of Psychiatry, 188: 547–53.
Rost, K., Smith, J. and Dickinson, M. (2004) The effect of improving primary care depression
management on employee absenteeism and productivity: a randomised trial,
Medical Care, 42(12): 1202–10.
Salize, H.J. and Rossler, W. (1996) The cost of comprehensive care of people with schizophrenia
living in the community: a cost evaluation from a German catchment area,
British Journal of Psychiatry, 169(1): 42–8.
Salvador-Carulla, L., Tibaldi, G., Johnson, S., Scala, E. et al. (2005) Patterns of mental health
service utilisation in Italy and Spain. An investigation using the European Service
Mapping Schedule, Social Psychiatry and Psychiatric Epidemiology, 40(2): 149–59.
Sartorius, N. (2002) Iatrogenic stigma of mental illness, British Medical Journal, 324:
1470–1.
Schlesinger, M. and Dorwart, R. (1984) Ownership and mental-health services: a
reappraisal of the shift toward privately owned facilities, New England Journal of
Medicine, 311(15): 959–65.
Scott, S., Knapp, M., Henderson, J. and Maughan, B. (2001) Financial cost of social exclusion:
follow up study of antisocial children into adulthood, British Medical Journal,
323(7306): 191.
Simon, G., Katon, W., von Korff, M. et al. (2001) Cost-effectiveness of a collaborative care
program for primary care patients with persistent depression, American Journal of
Psychiatry, 158: 1638–44.
Soumerai, S.B., McLaughlin, T.J., Ross-Degnan, D., Casteris, C.S. and Bollini, P. (1994)
Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic
agents and acute mental health services by patients with schizophrenia, New England
Journal of Medicine, 331(10): 650–5.
Tamblyn, R., Laprise, R., Hanley, A. et al. (2001) Adverse events associated with prescription
drug cost-sharing among poor and elderly persons, Journal of the American
Medical Association, 285(4): 421–9.
ten Have, M., Vollebergh, W., Bijl, R. and Nolen, W.A. (2002) Bipolar disorder in the
general population in the Netherlands (prevalence, consequences and care utilisation):
results from The Netherlands Mental Health Survey and Incidence Study
(NEMESIS), Journal of Affective Disorders, 68(2–3): 203–13.
Thomas, C. and Morris, S. (2003) Cost of depression among adults in England in 2000,
British Journal of Psychiatry, 183: 514–19.
Tomasson, K. (2004) Financing Mental Health Systems – Iceland. Report prepared for the
Mental Health Economics European Network, http://www.mhe-sme.org/en/projects_
mheii.htm.
Tomov, T., Mladenova, M., Lazarova, I., Sotirov, V. and Okoliyski, M. (2004) Bulgaria
mental health country profile, International Review of Psychiatry, 16(1–2): 93–106.
Weich, S. and Lewis, G. (1998) Material standard of living, social class and the prevalence
of common mental disorders in Great Britain, Journal of Epidemiology and Community
Health, 52(1): 8–14.
World Health Organization (2000) The World Health Report 2000. Health Systems: Improving
Performance. Geneva: World Health Organization.
World Health Organization (2005a) Atlas. Mental Health Resources Around the World.
Geneva: World Health Organization.